PKMYT1 and neoplasm: RP-6306 treatment induced pan-γH2AX in an HCC1569 breast cancer cell line, indicating that tumour-derived CCNE1 amplification also renders cells vulnerable to DNA damage induction following PKMYT1 inhibition (Fig. 3c, Extended Data Fig. 4a, b).